References 1 KFF, November 2025 2 KFF, November 2025 3 Beth Israel Deaconess Medical Center, November 2024 4 Baylor Scott & White Health, May 2026 5 Tufts Medicine, August 2025 6 Cornell Chronicle, September 2025 7 Curion, March 2026 8 WSJ, GLP-1 Users Are Taking a Bite Out of the Restaurant Business, May 13, 2026 9 Northwestern Now, November 2024 10 Northwestern Now, November 2024 For more information, visit harmelin.com, or connect with us on LinkedIn or Facebook.
C., Li, Y
SGLT2i, sodium-glucose co-transporter-2 inhibitor
Individuals who are overweight or have a Body Mass Index (BMI) of 30 or higher, indicating obesity People with health issues such as diabetes, high blood pressure, or high cholesterol Those who are in the process of weight loss and require additional support Individuals seeking to reduce unhealthy snacking habits People who have not seen results from other weight-loss methods, such as non-standard weight loss medications Anyone looking for a safe weight-loss solution with no side effects or risk of yo-yo weight gain Who Should Not Use the GLP-1
There are many ways to take care of your heart and reduce the risk of heart disease when living with diabetes cholesterol lowering medications (statins), smoking cessation, and aerobic exercise are especially important
It doesnt involve clinics, appointments, or injections
